Retailers warn SNAP restrictions threaten consumer access
Retail associations urge USDA to extend the implementation timeline and clarify national definitions of restricted foods.
Retail associations urge USDA to extend the implementation timeline and clarify national definitions of restricted foods.
By Harini Bupathi, Esq. partner, Frier Levitt’s Life Sciences Group
The event will gather leaders from public and private sectors to discuss how retail can improve health outcomes nationwide.
Losses in trade, transport and leisure point to consumer-facing sectors under pressure as employers pull back on hiring.
New analysis of metro-area data reveals wide variation in adult vaccination trends across the US and points to opportunities for local action.
Halloween is falling on a Friday for the first time in more than a decade, which means more celebrations, more trick-or-treaters and more fun.
The company said it is removing synthetic dyes and more than 30 other ingredients.
“This revised proposal is critical to preventing the rule from unnecessarily driving up grocery prices."
Unified brand brings together Amazon Fresh and Happy Belly customer favorites and new offerings.
Prices of more than 300 items across 28 product categories will be reduced by an average of 17%.
Investment strengthens local organizations to advance food access, workforce development, and housing stability in underserved communities.
Leveraging the strength of the CVS Health family of companies to deliver differentiated member experiences.
Grip, Rip, Dip and enjoy Kraft Mac & Cream Cheese schmear at all PopUp Bagels locations for a limited time this month.
Instacart and Advantage Solutions are partnering to provide CPGs with real-time visibility into on-shelf conditions, enabling brands to identify gaps and take immediate action.
“The President’s announcement reflects the reality that pharmacy benefit manager (PBM) tactics are exploding Americans’ prescription drug costs, and this action is an attempt to strike a blow against the PBMs’ manipulation and self-enrichment in the prescription drug supply chain."
FDA declined to issue guidance or rulemaking, which CRN said will stifle innovation and perpetuate conflict between supplement makers and pharmaceutical companies.